Metachronous Lung Cancer After Pleurectomy/Decortication

Yuichiro Kai; Yasuhiro Tsutani; Masaoki Ito; Takeshi Mimura; Yoshihiro Miyata; Morihito Okada

doi:10.1016/j.athoracsur.2018.05.087

Metachronous Lung Cancer After Pleurectomy/Decortication

Ann Thorac Surg. 2019 Jan;107(1):e1-e3. doi: 10.1016/j.athoracsur.2018.05.087. Epub 2018 Jul 3.

Authors

Yuichiro Kai¹, Yasuhiro Tsutani¹, Masaoki Ito¹, Takeshi Mimura¹, Yoshihiro Miyata¹, Morihito Okada²

Affiliations

¹ Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
² Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. Electronic address: morihito@hiroshima-u.ac.jp.

PMID: 30558734
DOI: 10.1016/j.athoracsur.2018.05.087

Abstract

Pleurectomy/decortication is a surgical procedure for malignant pleural mesothelioma (MPM) and has been proposed as an alternative to extrapleural pneumonectomy. We report a second primary lung cancer developing after pleurectomy/decortication for MPM. A 59-year-old man was diagnosed with MPM on the right side and underwent pleurectomy/decortication. Follow-up computed tomography detected a nodule in the right upper lobe that was diagnosed as adenocarcinoma by wedge resection. Lung cancer and MPM are associated with asbestos exposure. However, predicting lung cancer after treatment for MPM is difficult. Careful follow-up of the spared lung is necessary for detecting second primary lung cancer or MPM recurrence.